BioBrewhouse: Computional power, Artificial Intelligence and Biotech

Date

Thursday, May 23rd 2024 (17:00)

Location

Gaston Geenslaan 1, 3001 Leuven, Belgium

Organised by

Bio-Incubator Leuven, flanders.bio, Leuven Mindgate

Categories

Tags

We would like to invite you to the fifth edition of the BioBrewhouse on Thursday May 23, starting at 5 pm. The concept is known, bringing great innovative biotech minds together in an informal setting.

Where in our daily life the ever increasing computational power has led to a hype on artificial intelligence, no less will it impact biotechnology.

We have the honor to welcome profs. Thierry Voet and Alejandro Sifrim for a talk on Single-cell and spatial multi-omics for biomedicine.

Organized by

  • Bio-Incubator Leuven

  • flanders.bio

  • Leuven Mindgate

Venue

auditorium at Bio-Incubator 4, Gaston Geenslaan 3, Heverlee

Program

  • 17h: welcome drink

  • 17.30h: presentation by profs. Thierry Voet and Alejandro Sifrim

  • 18h: informal Q&A and networking

Speakers

  • Prof. Thierry Voet, Director of the KU Leuven Institute for Single Cell Omics

  • Prof. Alejandro Sifrim, Founding member of the KU Leuven Institute for Single Cell Omics

About the presentation

Single-cell and spatial omics (SCS-omics) are key to generate breakthrough insights across life sciences by deconstructing on the one hand complex biological systems to their fundamental unit –the individual cell– and by capturing on the other hand the spatial context within which their biology occurs. Because a cell’s function is determined by the interplay between a molecular hierarchy –i.e., its genome, epigenome, transcriptome, proteome, lipidome and metabolome– there is a strong need for SCS-omics to enable multi-omics readouts of single cells and their cellular communities. In addition, to extract meaningful insights from such complex datasets of many thousands to multiple millions of cells sampled from human (diseased) tissues with associated clinical metadata, new computational tools enhanced with Artificial Intelligence (AI) and statistical modelling are needed. Such end-to-end technological advances in SCS-omics bear the enormous potential to revolutionize precision medicine by generating new molecular and cellular insights in the etiopathogenesis of diseases.

Your hosts

  • Patrik De Haes, Chairman at BioBrewhouse

  • Michael De Blauwe, General Manager Bio-Incubator Leuven

  • Wouter Piepers, CEO flanders.bio

  • Jan Paesen, Managing Director Leuven MindGate

Registration

With only limited seats, please confirm your attendance to annelies@bio-incubator.be (a no-show is an opportunity missed for someone else).